Effect of Cell Differentiation for Neuroblastoma by Vitamin K Analogs
Open Access
- 3 February 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 39 (4), 251-259
- https://doi.org/10.1093/jjco/hyp011
Abstract
Lack of receptor tyrosine kinase (TrkA), a high-affinity nerve growth factor (NGF) receptor, is closely associated with the malignant progression of neuroblastoma (NB) and its prognosis. Vitamin K3 (VK3) analogs inhibit the activity of protein tyrosine phosphatases (PTPases), which causes hydrolysis of the phosphate groups bound to the tyrosine residues on tyrosine kinase, resulting in sustained tyrosine phosphorylation. In order to reverse this abnormal NGF/TrkA signal transduction in NB cells, we synthesized new VK3 analogs and examined their activity against NB cells. VK3 analogs increased or maintained the expression level of c-fos mRNA in the NB cells, which express the downstream genes of NGF/TrkA signal transduction. Moreover, the expression level of GAP-43 mRNA, which is a marker of neurite outgrowth and neuronal differentiation, was increased and morphological differentiation was also observed. VK3 analogs (especially COOH analog) continued to express c-fos and GAP-43 mRNAs and induced differentiation of NB cells after stimulation of NGF by strong inhibition of PTPase without affecting TrkA autophosphorylation. Vitamin K3 analogs may have potential as clinical therapeutic agents for NB.Keywords
This publication has 16 references indexed in Scilit:
- Phosphorylation regulates Myc expression via prolonged activation of the mitogen‐activated protein kinase pathwayJournal of Cellular Physiology, 2006
- Oncogenic rearrangements of the NTRK1/NGF receptorCancer Letters, 2006
- Biological effects of TrkA and TrkB receptor signaling in neuroblastomaCancer Letters, 2005
- NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell numberOncogene, 2003
- K vitamins, PTP antagonism, and cell growth arrestJournal of Cellular Physiology, 2002
- Signal Transduction Pathways through TRK‐A and TRK‐B Receptors in Human Neuroblastoma CellsJapanese Journal of Cancer Research, 2001
- Growth Inhibition of Hepatoma Cells Induced by Vitamin K and Its AnalogsPublished by Elsevier BV ,1995
- trk and ret proto‐oncogene expression in human neuroblastoma specimens: High frequency of trk expression in non‐advanced stagesInternational Journal of Cancer, 1993
- The trk proto-oncogene encodes a receptor for nerve growth factorCell, 1991
- The neurocristopathiesA unifying concept of disease arising in neural crest maldevelopmentHuman Pathology, 1974